Suchergebnisse - "Le Terrier, Christophe"

PubPharm (53)

1

Effect of modification of penicillin-binding protein 3 on susceptibility to ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam, cefepime-taniborbactam, and cefiderocol of Escherichia coli strains producing broad-spectrum β-lactamases

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Le Terrier, C. | Nordmann, P. | Buchs, C. | +1

2

Pulmonary embolism impacts clinical outcomes of intubated patients with acute respiratory distress syndrome related to COVID-19

enthalten in: Anaesthesia, critical care & pain medicine | 2024

von Primmaz, S. | Rochat Negro, T. | Suh, N. | +4

3

Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Le Terrier, C. | Viguier, C. | Nordmann, P. | +2

4

Structural basis of metallo-β-lactamase resistance to taniborbactam

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Drusin, S. | Le Terrier, C. | Poirel, L. | +3

5

Reduced susceptibility to aztreonam-avibactam conferred by acquired AmpC-type β-lactamases in PBP3-modified Escherichia coli

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2024

von Helsens, N. | Sadek, M. | Le Terrier, C. | +2

6

Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility/resistance to cefiderocol : which are the best present and future therapeutic alternatives?

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2024

von Le Terrier, C. | Freire, S. | Nordmann, P. | +1

7

enthalten in: Revue medicale suisse | 2023

von Schmutz, T. | Le Terrier, C. | Schwaller, J. | +2

8

Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility/resistance to cefiderocol: which are the best present and future therapeutic alternatives?

enthalten in: European journal of clinical microbiology & infectious diseases | 2023

von Le Terrier, C. | Freire, S. | Nordmann, P. | +1

9

Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Escherichia coli

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Le Terrier, C. | Nordmann, P. | Bouvier, M. | +1

10

Anaesthetic and peri-operative management for thrombectomy procedures in stroke patients

enthalten in: Anaesthesia, critical care & pain medicine | 2023

von Le Terrier, C. | Sigaut, S. | Abou Arab, O. | +1

1
2
3
4
5
6
Nächster »
[6]